Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

Role of tumor-associated macrophages in relation to angiogenesis in urothelial bladder carcinoma

Role of Trop2, Cyclin D1 and FOXP3 in bladder carcinoma in Egyptian patients: An immunohistochemical study

Immunohistochemical Study of PDL-1 Expression in Urinary Bladder Carcinoma

Prognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer

The Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study

High expression of the checkpoint molecule PD-1 on regulatory and helper CD4+ T cells in metastatic breast cancer patients with poor prognosis

Expression of programmed death ligand 1 (PD-L1) in urothelial bladder carcinoma (immunohistochemical and histopathological study)

Tumour-associated macrophages (IL-23+CD14+ subset) levels during bladder cancer progression